Silver Book Fact

Between August 2004 and July 2014, the FDA approved:

  • Six new anticancer therapeutics
  • Five new uses for previously approved anticancer therapeutics
  • Two new uses for imaging agents
  • One new use for a screening test

AACR Cancer Progress Report 2014. Clin Cancer Res Web site. http://clincancerres.aacrjournals.org/content/20/19/4977.full. Published 2014

Reference

Title
AACR Cancer Progress Report 2014
Publication
Clin Cancer Res
Publication Date
Published 2014
Authors
American Association for Cancer Research
Volume & Issue
Volume 20, Issue S1
Pages
S1-S112
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Every additional dollar spent on newer, less toxic hormonal therapy for breast cancer patients has produced health gains valued at between $27.03 and $36.81.  
  • Death rates from breast cancer declined by an average of 2.3% per year between 1990 and 2002 because of earlier detection through screening, better awareness, and improved treatments.  
  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.  
  • The 1-year survival rate for lung cancer has increased from 37% in 1975 to 42% in 1999-2001, largely because of improvements to surgical techniques and with combined therapies.  
  • There are 3 million more cancer survivors today than there were a decade ago.